RNA疫苗-话题@MedSci

#RNA疫苗#

127篇内容 | 3076人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1947452, encodeId=8ea4194e4522a, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=bioRxiv：全球首款冻干mRNA疫苗，来自中国团队，可在25℃下长期稳定, objectType=article, longId=295732, objectId=9b66295e32da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b66295e32da, replyNumber=0, likeNumber=73, createdTime=2022-12-12, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b66295e32da, moduleTitle=bioRxiv：全球首款冻干mRNA疫苗，来自中国团队，可在25℃下长期稳定, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b66295e32da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947460, encodeId=76aa194e460bb, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=上海推动新冠病毒疫苗注册上市，序贯接种国产mRNA疫苗何时成真？, objectType=article, longId=302286, objectId=c2863022869b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2863022869b, replyNumber=0, likeNumber=87, createdTime=2022-04-19, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2863022869b, moduleTitle=上海推动新冠病毒疫苗注册上市，序贯接种国产mRNA疫苗何时成真？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2863022869b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947430, encodeId=fe0a194e4302c, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=mRNA疫苗保护力5个月后大幅降低，首款新冠口服药即将获批 | 新冠研究新近进展, objectType=article, longId=218380, objectId=86992183805b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86992183805b, replyNumber=0, likeNumber=74, createdTime=2022-05-26, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86992183805b, moduleTitle=mRNA疫苗保护力5个月后大幅降低，首款新冠口服药即将获批 | 新冠研究新近进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86992183805b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947465, encodeId=83c0194e46591, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=EBioMedicine：与非产后妇女相比，新型冠状病毒mRNA疫苗诱导了针对相关变异体的更高的抗体亲和力和IgG滴度, objectType=article, longId=723794, objectId=1842e2379434, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1842e2379434, replyNumber=0, likeNumber=108, createdTime=2022-04-22, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1842e2379434, moduleTitle=EBioMedicine：与非产后妇女相比，新型冠状病毒mRNA疫苗诱导了针对相关变异体的更高的抗体亲和力和IgG滴度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1842e2379434)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947471, encodeId=1e65194e471c3, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=2022年4月28日简报：美国CDC和欧盟认为其人口60%感染过新冠病毒，福奇称美国已走出大流行阶段；中国台湾新增8923例新冠确诊病例；未来复星医药和沃森生物旗下mRNA疫苗一起获批紧急使用的可能性较大, objectType=article, longId=725668, objectId=a2b4e25668e9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2b4e25668e9, replyNumber=0, likeNumber=60, createdTime=2022-09-21, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2b4e25668e9, moduleTitle=2022年4月28日简报：美国CDC和欧盟认为其人口60%感染过新冠病毒，福奇称美国已走出大流行阶段；中国台湾新增8923例新冠确诊病例；未来复星医药和沃森生物旗下mRNA疫苗一起获批紧急使用的可能性较大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2b4e25668e9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947451, encodeId=df29194e451b9, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=告别针头注射：口服胶囊mRNA疫苗要来了，灵感来自乌龟, objectType=article, longId=295030, objectId=b8d9295030c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8d9295030c3, replyNumber=0, likeNumber=69, createdTime=2022-09-20, rootId=0, userName=医者仁心, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8d9295030c3, moduleTitle=告别针头注射：口服胶囊mRNA疫苗要来了，灵感来自乌龟, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8d9295030c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947425, encodeId=5206194e425d7, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=2021年拉斯克奖出炉，mRNA疫苗两位先驱获奖，也基本敲定诺贝尔奖, objectType=article, longId=217651, objectId=0b1621e651a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b1621e651a4, replyNumber=0, likeNumber=98, createdTime=2022-05-30, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b1621e651a4, moduleTitle=2021年拉斯克奖出炉，mRNA疫苗两位先驱获奖，也基本敲定诺贝尔奖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b1621e651a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947462, encodeId=138a194e4625b, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=登上Cell：魏文胜团队开发环状RNA疫苗，对德尔塔和奥密克戎有效, objectType=article, longId=723641, objectId=4ecee2364196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ecee2364196, replyNumber=0, likeNumber=79, createdTime=2022-07-06, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ecee2364196, moduleTitle=登上Cell：魏文胜团队开发环状RNA疫苗，对德尔塔和奥密克戎有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ecee2364196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947427, encodeId=bdd2194e42780, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=国药集团中国生物复诺健mRNA疫苗产业化基地开工，国内又一mRNA疫苗生产线, objectType=article, longId=217713, objectId=886f21e71368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=886f21e71368, replyNumber=0, likeNumber=66, createdTime=2022-03-07, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=886f21e71368, moduleTitle=国药集团中国生物复诺健mRNA疫苗产业化基地开工，国内又一mRNA疫苗生产线, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=886f21e71368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947468, encodeId=8182194e46868, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Lancet子刊：第三针mRNA疫苗随着时间延长，有效性持续下降到53%, objectType=article, longId=724916, objectId=8589e24916f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8589e24916f2, replyNumber=0, likeNumber=81, createdTime=2023-03-20, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8589e24916f2, moduleTitle=Lancet子刊：第三针mRNA疫苗随着时间延长，有效性持续下降到53%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8589e24916f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947448, encodeId=d3e3194e448d0, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=JAMA：与辉瑞相比，Moderna的mRNA疫苗接种后突破性感染更少，住院更少, objectType=article, longId=294484, objectId=d81c294484b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d81c294484b9, replyNumber=0, likeNumber=68, createdTime=2022-10-18, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d81c294484b9, moduleTitle=JAMA：与辉瑞相比，Moderna的mRNA疫苗接种后突破性感染更少，住院更少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d81c294484b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947449, encodeId=64ec194e449b0, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Lancet microb：国产新冠mRNA疫苗临床I期结果公布，10个关键信息披露进展, objectType=article, longId=294845, objectId=815d29484541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=815d29484541, replyNumber=0, likeNumber=76, createdTime=2022-06-28, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=815d29484541, moduleTitle=Lancet microb：国产新冠mRNA疫苗临床I期结果公布，10个关键信息披露进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=815d29484541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947435, encodeId=4c6b194e43569, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Nature Biomedical Engineering：吸入式雾化LNP，递送mRNA疫苗，成功治疗致命性流感, objectType=article, longId=219259, objectId=c3af219259af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3af219259af, replyNumber=0, likeNumber=95, createdTime=2022-03-24, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3af219259af, moduleTitle=Nature Biomedical Engineering：吸入式雾化LNP，递送mRNA疫苗，成功治疗致命性流感, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3af219259af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947475, encodeId=2015194e475c2, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=NEJM：新冠病毒最新突变株亚型BA.4/5和BA.2.12.1对mRNA疫苗及奥密克戎自然感染的免疫逃避, objectType=article, longId=730018, objectId=0af8e3001813, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0af8e3001813, replyNumber=0, likeNumber=71, createdTime=2023-05-04, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0af8e3001813, moduleTitle=NEJM：新冠病毒最新突变株亚型BA.4/5和BA.2.12.1对mRNA疫苗及奥密克戎自然感染的免疫逃避, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0af8e3001813)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947420, encodeId=e8b0194e42064, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Nat Med：BNT162b2 mRNA疫苗对于孕妇的效果分析, objectType=article, longId=216962, objectId=0e6f2169622f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e6f2169622f, replyNumber=0, likeNumber=82, createdTime=2022-01-02, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e6f2169622f, moduleTitle=Nat Med：BNT162b2 mRNA疫苗对于孕妇的效果分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e6f2169622f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947464, encodeId=804e194e464d9, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Nature：新冠病毒ADE效应？新冠病毒可借助自然感染产生的抗体感染免疫细胞！但是mRNA疫苗产生的抗体是安全的, objectType=article, longId=723936, objectId=59ace239361b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59ace239361b, replyNumber=0, likeNumber=63, createdTime=2023-01-04, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59ace239361b, moduleTitle=Nature：新冠病毒ADE效应？新冠病毒可借助自然感染产生的抗体感染免疫细胞！但是mRNA疫苗产生的抗体是安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59ace239361b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947466, encodeId=c40a194e466e8, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=Clin Infect Dis：新加坡真实世界研究揭示mRNA疫苗与灭活疫苗在防止新冠病毒感染和重症风险中的作用, objectType=article, longId=724327, objectId=3dc2e24327c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dc2e24327c8, replyNumber=0, likeNumber=80, createdTime=2023-02-22, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dc2e24327c8, moduleTitle=Clin Infect Dis：新加坡真实世界研究揭示mRNA疫苗与灭活疫苗在防止新冠病毒感染和重症风险中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3dc2e24327c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947472, encodeId=105a194e47237, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=NEJM：接种第四剂Covid-19 mRNA疫苗BNT162b2的效果如何？, objectType=article, longId=725705, objectId=4953e25705ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4953e25705ca, replyNumber=0, likeNumber=68, createdTime=2022-10-01, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4953e25705ca, moduleTitle=NEJM：接种第四剂Covid-19 mRNA疫苗BNT162b2的效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4953e25705ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947455, encodeId=854c194e45577, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=新冠疫苗可混合接种，不过终究还是没等来mRNA疫苗, objectType=article, longId=299294, objectId=2eb529929407, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2eb529929407, replyNumber=0, likeNumber=86, createdTime=2022-10-09, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2eb529929407, moduleTitle=新冠疫苗可混合接种，不过终究还是没等来mRNA疫苗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2eb529929407)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1947459, encodeId=6381194e4592a, content=<a href='/topic/show?id=88d81556543' target=_blank style='color:#2F92EE;'>#RNA疫苗#</a>, objectTitle=超越mRNA疫苗？可应对新冠突变株的环状RNA疫苗来啦, objectType=article, longId=302232, objectId=55493022323d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55493022323d, replyNumber=0, likeNumber=70, createdTime=2022-09-01, rootId=0, userName=12498b3em08(暂无昵称), userId=ce072500140, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55493022323d, moduleTitle=超越mRNA疫苗？可应对新冠突变株的环状RNA疫苗来啦, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55493022323d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

RNA疫苗

2020-05-29

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

bioRxiv：全球首款冻干mRNA疫苗，来自中国团队，可在25℃下长期稳定

2022-12-12

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

上海推动新冠病毒疫苗注册上市，序贯接种国产mRNA疫苗何时成真？

2022-04-19

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

mRNA疫苗保护力5个月后大幅降低，首款新冠口服药即将获批 | 新冠研究新近进展

2022-05-26

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

EBioMedicine：与非产后妇女相比，新型冠状病毒mRNA疫苗诱导了针对相关变异体的更高的抗体亲和力和IgG滴度

2022-04-22

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

2022年4月28日简报：美国CDC和欧盟认为其人口60%感染过新冠病毒，福奇称美国已走出大流行阶段；中国台湾新增8923例新冠确诊病例；未来复星医药和沃森生物旗下mRNA疫苗一起获批紧急使用的可能性较大

2022-09-21

医者仁心 (审核中...)

前往app查看评论内容

#RNA疫苗#

告别针头注射：口服胶囊mRNA疫苗要来了，灵感来自乌龟

2022-09-20

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

2021年拉斯克奖出炉，mRNA疫苗两位先驱获奖，也基本敲定诺贝尔奖

2022-05-30

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

登上Cell：魏文胜团队开发环状RNA疫苗，对德尔塔和奥密克戎有效

2022-07-06

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

国药集团中国生物复诺健mRNA疫苗产业化基地开工，国内又一mRNA疫苗生产线

2022-03-07

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Lancet子刊：第三针mRNA疫苗随着时间延长，有效性持续下降到53%

2023-03-20

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

JAMA：与辉瑞相比，Moderna的mRNA疫苗接种后突破性感染更少，住院更少

2022-10-18

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Lancet microb：国产新冠mRNA疫苗临床I期结果公布，10个关键信息披露进展

2022-06-28

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Nature Biomedical Engineering：吸入式雾化LNP，递送mRNA疫苗，成功治疗致命性流感

2022-03-24

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

NEJM：新冠病毒最新突变株亚型BA.4/5和BA.2.12.1对mRNA疫苗及奥密克戎自然感染的免疫逃避

2023-05-04

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Nat Med：BNT162b2 mRNA疫苗对于孕妇的效果分析

2022-01-02

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Nature：新冠病毒ADE效应？新冠病毒可借助自然感染产生的抗体感染免疫细胞！但是mRNA疫苗产生的抗体是安全的

2023-01-04

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

Clin Infect Dis：新加坡真实世界研究揭示mRNA疫苗与灭活疫苗在防止新冠病毒感染和重症风险中的作用

2023-02-22

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

NEJM：接种第四剂Covid-19 mRNA疫苗BNT162b2的效果如何？

2022-10-01

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

新冠疫苗可混合接种，不过终究还是没等来mRNA疫苗

2022-10-09

12498b3em08(暂无昵称) (审核中...)

前往app查看评论内容

#RNA疫苗#

超越mRNA疫苗？可应对新冠突变株的环状RNA疫苗来啦

2022-09-01

科室
- - 订阅+
  - 更多科室
工具
服务